Role of Retinol Binding Protein -4(RBP-4) and some Biochemical Parameters in Type II Diabetes Mellitus Patients

Noor Ghassan Elias; Raghda Shams Akram; Maryam Qusay Isaa

doi:10.55544/jrasb.2.5.31

Authors

Noor Ghassan Elias Middle Technical University College of Health and Medical Techniques, Baghdad, IRAQ.
Raghda Shams Akram Middle Technical University College of Health and Medical Techniques, Baghdad, IRAQ.
Maryam Qusay Isaa Middle Technical University, Institute of Medical Technology AL-Mansure, Baghdad, IRAQ.

DOI:

https://doi.org/10.55544/jrasb.2.5.31

Keywords:

T2DM, Retinol Binding Protein-4, HbA1c, Lipid profile, FBS

Abstract

Diabetes is an important public health issue that adversely affects the lives of millions of individuals worldwide. RBP4 involvement in the pathogenesis of insulin resistance and type 2 diabetes. The aim of this study to assessment of role retinol binding protein -4 and other biochemical parameters in T2DM. Eighty eight participated in this study. Forty four T2DM, age between (40-60) years and forty four healthy control age between (40-55). there was a highly significant increase of FBS, HbA1C, TC, TG, LDL-C and VLDL-C, while a significant decreased of HDL-C between control and T2DM patients. There was a highly significant increase of RBP-4 level between different group (control and T2DM patients). Conclusion: Elevation of retinol in diabetic patients is considered a risk indicator for them with the early onset of cardiovascular disease, and this is a result of the continuous increase in the concentrations of sugar levels in the blood, and thus a defect in the metabolism of fats occurs, which leads to its rise, and this is an indicator of the entry of a diabetic patient with one of the complications, which is heart disease.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

WU, Haibin, et al. How do type 2 diabetes mellitus related complications and socioeconomic factors impact direct medical costs A cross-sectional study in rural Southeast China. BMJ open, 2018, 8.11: e020647.

International Diabetes Federation (IDF). IDF diabetes atlas. 7th edn, 2015. (Accessed 17 Oct 2017).

Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA 2017;317:2515– 23.

AHMED, Fahd, et al. Impact of triglycerides and waist circumference on insulin resistance and β-cell function in non- diabetic first-degree relatives of type 2 diabetes. BMC Endocrine Disorders, 2021, 21.1: 1-8.

VLADU, IonelaMihaela, et al. Insulin resistance quantified by the value of HOMA-IR and cardiovascular risk in patients with type 2 diabetes. Experimental and Therapeutic Medicine, 2022, 23.1: 1-6.

Dilaveris P, Antoniou CK, Manolakou P, Tsiamis E, Gatzoulis K, Tousoulis D. Biomarkers associated with atrial fibrosis and remodeling. Current Medicinal Chemistry. 2019 Feb 1;26(5):780- 802.

WANG, Yeli, et al. Retinol binding protein 4 and risk of type 2 diabetes in Singapore Chinese men and women: a nested case- control study. Nutrition & metabolism, 2019, 16.1: 1-11.

ZHANG, Li, et al. The role of circulating RBP4 in the type 2 diabetes patients with kidney diseases: a systematic review and meta-analysis. Disease markers, 2020, 2020.

LARISSA, Zvenigorodskaya, et al. Retinol-binding protein in the diagnosis nafld and type 2 diabets. In: Endocrine Abstracts. Bioscientifica, 2021. DOI: 10.1530/endoabs.70.AEP452.

WOLF, George. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes. Nutrition reviews, 2007, 65.5: 251-256. https://doi.org/10.1111/j.1753-4887.2007.tb00302.x

ALAPATT, Philomena, et al. Liver retinol transporter and receptor for serum retinol-binding protein (RBP4). Journal of Biological Chemistry, 2013, 288.2: 1250-1265.

Young PA, Leonard S, Martin DS, Findlay JB. Analysis of the effect of a novel therapeutic for type 2 diabetes on the proteome of a muscle cell line. Proteomics. 2016 Jan;16(1):70-9. doi: 10.1002/pmic.201500050. Epub 2015 Dec 12. PMID: 26573124.

Broch M, Gómez JM, Auguet MT, Vilarrasa N, Pastor R, Elio I, Olona M, García-España A, Richart C. Association of retinol-binding protein-4 (RBP4) with lipid parameters in obese women. Obes Surg. 2010 Sep;20(9):1258-64. doi: 10.1007/s11695-010-0200-5. PMID: 20544399.

Ji Y, Song J, Su T, Gu X. Adipokine Retinol Binding Protein 4 and Cardiovascular Diseases. Front Physiol. 2022 Mar 2;13:856298. doi: 10.3389/fphys.2022.856298. PMID: 35309061; PMCID: PMC8924404.

Wessel H., Saeed A., Heegsma J., Connelly M. A., Faber K. N., Dullaart R. P. F. (2019). Plasma levels of retinol binding protein 4 relate to large VLDL and small LDL particles in subjects with and without type 2 diabetes. J. Clin. Med. 8:792. 10.3390/jcm8111792.

Vergès B., Guiu B., Cercueil J. P., Duvillard L., Robin I., Buffier P., et al. (2012). Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 32 3050–3057. 10.1161/ATVBAHA.112.255190.

Sasaki N., Ozono R., Higashi Y., Maeda R., Kihara Y. (2020). Association of insulin resistance, plasma glucose level, and serum insulin level with hypertension in a population with different stages of impaired glucose metabolism. J. Am. Heart Assoc. 9:e015546. 10.1161/JAHA.119.015546

Si Y, Liu J, Han C, Wang R, Liu T, Sun L. The correlation of retinol- binding protein-4 and lipoprotein combine index with the prevalence and diagnosis of acute coronary syndrome. Heart Vessels. 2020 Nov;35(11):1494-1501. doi: 10.1007/s00380-020-01627-8. Epub 2020 May 24. PMID: 32449048; PMCID: PMC7502440.

von Eynatten, M.; Lepper, P.M.; Liu, D.; Lang, K.; Baumann, M.; Nawroth, P.P.; Bierhaus, A.; Dugi, K.A.; Heemann, U.; Allolio, B.; et al. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 2007, 50, 1930–1937.

Erikstrup, C.; Mortensen, O.H.; Nielsen, A.R.; Fischer, C.P.; Plomgaard, P.; Petersen, A.M.; Krogh-Madsen, R.; Lindegaard, B.; Erhardt, J.G.; Ullum, H.; et al. RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes. Diabetes Obes. Metab. 2009, 11, 204–212.

Taskinen, M.R.; Borén, J. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis 2015, 239, 483–495

Wessel H, Saeed A, Heegsma J, Connelly MA, Faber KN, Dullaart RPF. Plasma Levels of Retinol Binding Protein 4 Relate to Large VLDL and Small LDL Particles in Subjects with and without Type 2 Diabetes. Journal of Clinical Medicine. 2019; 8(11):1792. https://doi.org/10.3390/jcm8111792.

JI, Yanjing, et al. Adipokine retinol binding protein 4 and cardiovascular diseases. Frontiers in Physiology, 2022, 13: 258.

Perumalsamy S, Ahmad WAW, Huri HZ. Retinol-Binding Protein- 4—A Predictor of Insulin Resistance and the Severity of Coronary Artery Disease in Type 2 Diabetes Patients with Coronary Artery Disease. Biology. 2021; 10(9):858. https://doi.org/10.3390/biology10090858

Tahir NT, ALfatlawi WR, Jedda WA. Ghrelin and Obestatin Levels as a Novel Marker in Iraqi Obese Children. Baghdad Science Journal. 2023.